“…For preparation of bio-based NEs many compounds of natural origin, including encapsulated active ingredients (e.g., essential oils; EOs), but also plant oils for NE oil phase (e.g., palm oil, rapeseed oil, sunflower oil etc.) (e.g., Raviadaran et al 2018;Kaci et al 2018;Abdou et al 2018), emulsifiers, biosurfactants or cosurfactants (e.g., Quillaja saponin, phospholipids, lecithin, gum arabic, pectin, whey protein, lactoferrin, lactoferrin/alginate) McClements and Gumus 2016;Ozturk et al 2014Ozturk et al , 2015Liu et al 2017;Verma et al 2016;Artiga-Artigas et al 2018;Zhao et al 2018a;Pinheiro et al 2016), or targeting ligands on the surface of NE such as folate (Liu et al 2017;Ganta et al 2016;Afzal et al 2016a) increasing drug bioavailability, reducing undesirable side effects, minimizing non-specific uptake and thus allowing specific targeting to certain target cells are used. Targeting technology usually utilizes the nanocarrier functionalization, which can be surface modification (e.g., Attia et al 2017;Liu et al 2017) and/or ligand grafting (e.g., Geng et al 2016).…”